The Carlyle Group
CG
37.80
-1.08
-2.78%
The Carlyle Group
US · CG
#1171 by market cap
Listed 1970
37.80
-1.08
-2.78%
Live - 5344 symbols - heartbeat 121s ago
· 2026-10-07 20:02
After-hours
37.80
0.00%
- Market cap
- 13.47B
- P/E (TTM)i
- 39.38
- P/Bi
- 2.57
- EPSi
- 2.18
- Div yieldi
- 3.70%
- 52W posi
- 1%
Reader sentiment
Are you bullish or bearish on CG?
Anonymous reader poll. Unscientific, not investment advice.
Recent news
-
Rating change
Morgan Stanley Maintains CG Oncology(CGON.US) With Buy Rating, Maintains Target Price $93Market Newswire · 2026/8/17
-
Rating change
Analysts' Opinions Are Mixed on These Healthcare Stocks: CG Oncology, Inc. (CGON) and Zimmer Biomet Holdings (ZBH)TipRanks · 2026/8/13
-
Rating change
A Quick Look at Today's Ratings for The Carlyle Group(CG.US), With a Forecast Between $50 to $73Market Newswire · 2026/8/7
-
Company notice
CG Oncology | 4: Statement of changes in beneficial ownership of securities-Officer Patterson Joshua F.SEC · 2026/4/17
-
Rating change
A Quick Look at Today's Ratings for CG Oncology(CGON.US), With a Forecast Between $85 to $108Market Newswire · 2026/8/8
-
Rating change
BofA Securities Maintains The Carlyle Group(CG.US) With Sell RatingMarket Newswire · 2026/8/8
-
Rating change
A Quick Look at Today's Ratings for CG Oncology(CGON.US), With a Forecast Between $79 to $100Market Newswire · 2026/8/7
-
Company notice
Dynamic Map Platform Co.,Ltd.: Dynamic Map Platform to Exhibit at Tokyo Game Show 2026; Engages in Information Exchange with 35 Domestic and International Companies in the Gaming, CG, and XR Sectors, Proposing the Utilization of Spatial Data for Games.JPX · 2026/9/25
-
Company notice
CG Oncology | 4: Statement of changes in beneficial ownership of securities-Officer DETORE JAMES M.SEC · 2026/4/17
-
Carlyle Group (CG.US) doubles down on energy sector with major C$1 billion acquisition of ParallaxZhitong Finance · 2026/9/15
-
Piper Sandler Initiates The Carlyle Group(CG.US) With Buy Rating, Announces Target Price $54Market Newswire · 2026/9/24
-
Rating change
UBS Maintains CG Oncology(CGON.US) With Buy Rating, Maintains Target Price $90Market Newswire · 2026/8/21
-
Rating change
Analysts' Top Healthcare Picks: CG Oncology, Inc. (CGON), Opus Genetics (IRD)TipRanks · 2026/9/10
-
The Carlyle Group(CG.US) Director Sells US$17.1 Million in Common StockMarket Newswire · 2026/9/12
-
Company notice
Dynamic Map Platform Co.,Ltd.: Utilizing high-precision 3D map data from the Dynamic Map Platform for CG production in the commercial for the third-generation Nissan LEAF.JPX · 2026/2/27
-
Form 144 | The Carlyle Group(CG.US) Director Proposes to Sell 17.23 Million in Common StocksMarket Newswire · 2026/9/12
-
Rating change
UBS Keeps Their Buy Rating on CG Oncology, Inc. (CGON)TipRanks · 2026/8/20
-
Company notice
CG SERVICES: ANNOUNCEMENT MADE PURSUANT TO RULES 13.51B(2) AND13.51(2)(n) OF THE LISTING RULESHKEX · 2026/2/11
-
Rating change
Truist Financial Maintains CG Oncology(CGON.US) With Buy Rating, Maintains Target Price $85Market Newswire · 2026/8/13
-
Truist Financial Maintains CG Oncology(CGON.US) With Buy RatingMarket Newswire · 2026/9/10
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-10-07 20:02:22 · For reference only, not investment advice and not tailored to your situation.